The role of gadolinium in triggering nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
Solomon
Garron Joseph
GJ
Rosen
Paul Peter
PP
Wu
Elizabeth
E
D003287:Contrast Media / Q000009:adverse effects*; D005355:Fibrosis / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D019786:Gadolinium DTPA / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D012871:Skin Diseases / Q000139:chemically induced* / Q000150:complications / Q000473:pathology
D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA